Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Circumferential Resection Margin
- Sponsor
- Beijing Chao Yang Hospital
- Enrollment
- 350
- Locations
- 1
- Primary Endpoint
- circumferential resection margin
- Last Updated
- 5 years ago
Overview
Brief Summary
For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.
Investigators
Zhen Jun Wang
Chairman of General Surgery
Beijing Chao Yang Hospital
Eligibility Criteria
Inclusion Criteria
- •Tumor within 12 cm of the anal verge
- •T3N1-2 as determined by preoperative MRI examination
- •negative circumferential resection margin determined by preoperative MRI examination
- •Absence of distant metastases
- •Absence of intestinal obstruction
Exclusion Criteria
- •With distant metastases
- •With intestinal obstruction
- •Pregnancy or lactation
- •With operation contraindication
- •With mental disorder
Outcomes
Primary Outcomes
circumferential resection margin
Time Frame: one week after operation
introperative perforation
Time Frame: During the operation
Secondary Outcomes
- local recurrece(3 years after operation)
- overal survival(3 years after operation)
- disease-free survival(3 years after operation)
- complications(30 days after operation)